Search Results
Results found for "RAGE Biotech"
- 📰 GPCR Weekly News, October 23 to 29, 2023
Find speaker details on the Live Talks page and mark your calendar HERE.
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Classified GPCR News from November 4th to 10th, 2024 Industry News Lexaria Updates Fast-Moving GLP-1 'Arm's Race
- 📰 GPCR Weekly News, June 19 to 25, 2023
GPCRs in Neuroscience Whole genome sequencing across clinical trials identifies rare coding variants
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
As a result, dimerized SecR receptors exhibit higher rates of G protein activation and release, improving
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair.
- 📰 GPCR Weekly News, May 1 to 7, 2023
Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
related peptides L-ATRP and D2-ATRP diastereomers activate an endogenous receptor and suppress heart rate
- Tectonic Therapeutic Strengthens Leadership Team
July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology
- Quantifying Receptor Selectivity in Modern Drug Discovery
Comparing Full and Partial Agonists Discovery programs rarely enjoy the simplicity of comparing two full
- Exploring the Breakthroughs in GPCR Research
Financial Results G-Protein Coupled Receptors Global Market 2024 To Reach $4.09 Billion By 2028 At Rate
- 📰 GPCR Weekly News, September 25 to October 1, 2023
You can find all the necessary information on the Logo Contest page.
- 📰 GPCR Weekly News, September 18 to 24, 2023
All information is available on the Logo Contest page.
- 📰 GPCR Weekly News, September 11 to 17, 2023
Since you are reading this newsletter, you only have to click on the event page to join us.
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
platform, today announced it has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Find speaker details on the Live Talks page and mark your calendar HERE.
- Targeting Intracellular Allosteric Sites in GPCRs
resulting change in conformation can influence the orthosteric binding pocket, potentially altering the rate
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Register today and save $200 off the current rate.
- Glyco-sulfo hotspots in the chemokine receptor system
monosaccharides (Schjoldager KT et al. 2020), and usually capped by a single sialic acid, although, in rare
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
revolutionize drug discovery by accelerating the process, optimizing drug design, and improving success rates






